Targeting erythroblast-specific apoptosis in experimental anemia

Abhinav Diwan, Andrew G. Koesters, Devan Capella, Hartmut Geiger, Theodosia A. Kalfa, Gerald W. Dorn

Research output: Contribution to journalArticlepeer-review

9 Scopus citations

Abstract

Erythrocyte production is regulated by balancing precursor cell apoptosis and survival signaling. Previously, we found that BH3-only proapoptotic factor, Nix, opposed erythroblast-survival signaling by erythropoietin-induced Bcl-xl during normal erythrocyte formation. Since erythropoietin treatment of human anemia has limitations, we explored the therapeutic potential of abrogating Nix-mediated erythroblast apoptosis to enhance erythrocyte production. Nix gene ablation blunted the phenylhydrazine-induced fall in blood count, enhanced hematocrit recovery, and reduced erythroblast apoptosis, despite lower endogenous erythropoietin levels. Similar to erythropoietin, Nix ablation increased early splenic erythroblasts and circulating reticulocytes, while maintaining a pool of mature erythroblasts as erythropoietic reserve. Erythrocytes in Nix-deficient mice showed morphological abnormalities, suggesting that apoptosis during erythropoiesis not only controls red blood cell number, but also serves a "triage" function, preferentially eliminating abnormal erythrocytes. These results support the concept of targeting erythroblast apoptosis to maximize erythrocyte production in acute anemia, which may be of value in erythropoietin resistance.

Original languageEnglish
Pages (from-to)1022-1030
Number of pages9
JournalApoptosis
Volume13
Issue number8
DOIs
StatePublished - Aug 2008

Keywords

  • Anemia
  • Apoptosis
  • Erythropoiesis
  • Erythropoietin

Fingerprint Dive into the research topics of 'Targeting erythroblast-specific apoptosis in experimental anemia'. Together they form a unique fingerprint.

Cite this